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Abstract 
Plasmodium falciparum remains a relevant global health pathogen with high levels of 
genomic variation and gene flow that could undermine malaria elimination strategies, 
especially in the high burden regions of Africa. Infections with P. falciparum remain complex 
across most of sub-Saharan Africa. SNP variants from 2263 isolates from 24 malaria endemic 
settings within 15 African countries classified into western, central and eastern ancestry, 
plus a divergent Ethiopian population. The parasite populations are interbred and share 
genomic haplotypes especially across drug resistance loci. Haplotypes across drug resistance 
associated loci showed the strongest recent identity-by-descent between populations and 
endogenous haplotypes have spread to and from all populations. A recent signature of 
selection on chromosome 12 with candidate resistance loci against artemisinin derivatives is 
evident in Ghana and Malawi. Such selection and emerging sub-structure may affect 
intervention strategies and the efficacy of drugs and vaccines for malaria elimination.  
 
Introduction 
The decline in global malaria prevalence is now reported to be stalling and elimination 
programmes will need additional knowledge, new tools and intervention strategies to meet 
global elimination milestones (1). The burden from Plasmodium falciparum in particular 
remains significant in Africa where it is prevalent across vast and varied vector, parasite and 
human populations (2, 3). While interventions drive down population sizes, reduce 
transmission and disconnect parasite populations, they can also drive selection, adaptation 
and population fragmentation. Population fragmentation and reduced diversity are 
therefore important parameters for consideration in refining approaches or tools for 
elimination(4). As massive interventions are implemented against falciparum malaria in 
Africa, it is imperative to determine if this has impacted the structure of the parasite 
population, which until recently has been considered as highly diverse and homogeneously 
interconnected(5). With higher density of genomic variants from next generation 
sequencing technologies, a better resolution of African P. falciparum populations is now 
possible. SNP markers for specific local populations or across several sites within geographic 
blocs have enabled the description of genomic variation and signatures of selection in 
Africa(6, 7). However, the ancestry, current structure and gene flow between P. falciparum 
across Africa remains unclear. 
The Plasmodium Diversity Network Africa (PDNA) has conducted P. falciparum genomic 
surveillance across Africa from the west Atlantic coast regions with high rainfall and 
perennial transmission; the Sahel with short rainy seasons and seasonal transmission; forest 
covered areas of Central Africa with perennial transmission; and Eastern Africa with 
perennial and seasonal transmissions to Ethiopia and the Island of Madagascar with co-
transmission of P. vivax(8). With high resolution sequence variants of P. falciparum isolates 
across Africa, we reveal the population structure, admixture, markers of identity-by-decent 
(IBD), differentiation and signatures of selection.  
 
Results 
SNP variants (29,998) were extracted from the genomes of 2263 Plasmodium falciparum 
isolates sampled from 24 sites within 15 African countries (figure 1a, and table S1 & S2). At 
least 55% of infections were polygenomic with up to 9 clones in some samples from Ghana, 
Guinea and Malawi (figure S1). The proportions of complex infections (i.e. lower mean Fws) 
was highest for isolates from sites in Kenya and least in Ethiopia (figure 1b). Malaria 
transmission intensity around the sampling site in Kenya (Kisumu, Lake Victoria) is high and 
will be driving the high infection complexity(9). In West Africa, isolates from Gambia and 
Senegal where the least polygenomic, confirming earlier reports of a decline in complexity 
with drop in prevalence, probably due to scale up of interventions(10).  
Standard principal component analysis (PCA) of genome haplotypes resolved 3 major groups 
of western (west Africa and the more central states of Cameroon and Gabon), eastern 
(DRCongo and all other sites in East Africa) and a distinct Ethiopian population (figure S2-
S4). This substructure was refined to 6 clusters from dimension reduction of ancestral 
membership coefficients, assuming 6 or 15 ancestral populations (figure 1c & d 
respectively).  
 
 
 
 
Figure 1. Sites, sample sizes and genetic groupings of P. falciparum isolates across PDNA and 
Pf3K studies in Africa. a) Sites, P. falciparum prevalence and studies from which SNP data of 
2263 isolates were accessed. b) Complexity of infections from sampling sites (countries). c) 
Scatter plot of dimension 1 and 2 from multidimensional scaling of tess3r ancestry 
coefficients for 6 ancestral populations or d) 15 ancestral populations clustered with t-sne. 
e) Isolation-by-distance heatmap from distribution of genetic and geographic distances 
between isolates from the different sampling sites colour coded by site of sampling. 
 
Six genetic clusters retained were west-African (WAF; Senegal, Gambia, Guinea, Mali, Cote 
D’Ivoire, Ghana, Nigeria), central-African (CAF; Cameroon and Gabon), south-central-African 
(SCAF; DRCongo), east-African (EAF; Kenya and Tanzania), south-east-African (SEAF; Malawi 
and Madagascar) and the horn-of-Africa (HAF; Ethiopia). Each cluster suggests an ancestral 
or transmission connectivity supported by geographic proximity and confirmed by 
significant isolation-by-distance (p=0.03), (figure 1e, figure S5). The major population 
continuums were within West and East with several fold difference in genetic distance (all 
FST values >0.1) between them and Ethiopia. This is indicative of differentiation due to 
factors beyond spatial separation and geographic barriers (western Cameroon forest, the 
equatorial forest, Congo basin rivers, and highlands of Ethiopia), (figure S6). These factors 
could include differences in human and vector populations as well as the history of 
interventions. Here, isolates from DRCongo and Ethiopia clustered away from geographically 
proximal sites in CAF and EAF respectively. Ethiopian human population has a unique 
ancestry from the rest of Africa, allowing sympatric transmission of Plasmodium vivax(11). 
P. falciparum isolates from neighbouring Djibouti also showed high genetic distances from 
other African populations (12). Like Madagascar, the human populations at the horn-of-
Africa have higher frequencies of the duffy antigen and P. vivax is co-transmitted. However, 
isolates from Madagascar clustered with those from Malawi, indicating ancestry from 
mainland despite human populations originating from South East Asia and separation by 
1,400 km of land and the Indian ocean (figure S5).  Co-prevalence of P. falciparum and P. 
vivax thus have a minor effect on the structure observed.   
 
 
 
Figure 2. Genome-wide ancestry proportions for P. falciparum isolates (admixture-like 
barplots) or populations (pie-charts) modelled to include donors from all sites (inc self) or 
excluding isolates from recipient sampling site (without self). a) ancestry per isolate (rows) 
from each sampling site (column1). b) median ancestry from each sampling site located on 
map. c) median ancestry proportions between isolates from each sampling site, excluding 
donors from same site. d) ancestry proportions for genetic clusters (column1). e) ancestry 
proportions for each population including self-copying (a) and, (b) without self-copying. 
 
Malaria parasites are believed to have jumped from western great apes to humans about 
10,000 years ago, prior to major human migration events (13). The donation of ancestral 
genome chunks from CAF to both west and eastern populations in this study aligns with this 
suggested origin followed by the spread through historical and more recent human 
migration in Africa. Early human migration from central African was dominated by bantu 
populations moving westwards and south-eastwards, after the emergence of malaria in 
humans (14). These historical links prior to dispersal of humans and parasites west and east 
of Africa will account for the shared ancestry between all populations (figure 2). Recent 
human migration from colonization and slavery may also have contributed to this structure. 
Here, significant ancestral chunks are shared between distal French colonies like Cameroon, 
Mali and Senegal, while ancestry from WAF sites of Mali, Guinea and Senegal are present in 
DRCongo. T-SNE and FineStructure clustering of ancestral chunk matrices also maintained 
the major west and eastern groupings and sub-populations, as well as confirming isolates 
from DRCongo to be more related to eastern populations. (figure S7 & S8). Mixing of 
populations could facilitate gene flow, IBD signatures and spread of adaptive alleles 
between populations (15). 
The proportions of isolates in IBD (<3%) was weak and uneven across the genome given 
intense recombination in Africa (figure 3a). However, high IBD proportions spanned twelve 
segments of the genome coding for candidate drug resistance loci; Pfaat1 (PF3D7_0629500) 
on chromosome 6; known drug resistance genes, Pfmdr1, Pfcrt and Pfdhps and a cluster of 
genes on chromosome 12 (Pfap2mu, PfATPase and Pfap2g2) (figure 3a & 3b, figure S8). 
These genes are involved in drug responses, transportation and metabolism (figure 3b & 3c). 
These results confirm links between Pfcrt and Pfaat1, which together with Pfap2g2 and 
Pfatpase2 have been identified as part of the malaria druggable genome (16). Pfap2mu in 
particular had been linked to artemisinin tolerance in Africa(17).  
 
 
Figure 3. Haplotype sharing across drug resistance loci identified by pairwise identity-by-
descent (IBD) and chromosome painting. a) IBD between pairs of P. falciparum isolates. IBD 
segment peaks highlighted at; multidrug resistance protein 1(mdr1), amino acid transporter 
1(aat1), chloroquine resistance transporter (crt), dihydropteroate synthetase (dhps), AP2 
domain transcription factors (AP2-G and AP2-mu) and aminophospholipid-transporting P-
ATPase (ATPase2). b) Genomic segments with high IBD proportions. c) enrichment of 
ontology terms for genes within IBD segments. d) Admixture-like barplots of acquired 
ancestry proportions per isolates (rows) across drug resistance loci including donors from 
same site (inc self) or from different sampling sites (without self). e) median ancestry 
proportions (pie charts) donated to each site by isolates from other sampling sites. e) 
ancestry for isolates classified by genetic cluster defined in figure 1. f) Median proportions 
of acquired drug resistance haplotypes from different groups into each of the main 
population clusters. 
With IBD detection limited within 25 generations, drug resistance haplotypes would have 
been recently and locally selected before sharing across Africa. Multiple local emergence 
was evident from the multiplicity of haplotype clusters for antifolate markers but also for 
Pfmdr1, which showed two ancestral lineages dominant in east and western populations 
respectively (figure S9). Multiple emergence of resistance against antifolates had been 
described, but not for a major quinoline resistance mediator such as Pfmdr1 (18). Haplotype 
painting across drug resistance loci, confirms bidirectional sharing across drug resistance loci 
(figure 3). Selection, emergence and spread of resistance to drugs is therefore feasible in all 
endemic sites across Africa. With treatment pressure from artemisinin derivatives and use 
of older drugs in preventive treatment, signs of differentiation and positive selection could 
inform future strategies to curb the process of drug adaptation. 
 
 
 
Figure 4. Signatures of differentiation and positive selection in P. falciparum populations 
from Africa. Heatmaps were clustered on rows for similar patterns within and between 
populations. SNP values are in columns separate by chromosomes for each population or 
pair of populations in rows. Low to high values are colour graded from azure to red on RGB 
colour wheel. a) Manhattan plot of median pairwise differentiation per SNP (FLK) between 
all genetic groups with isolates from Ethiopia defined as an outgroup. b) Weir and 
Cockerham’s index of fixation (Fst). c) Integrated haplotype score (iHS) per population 
grouping. d) cross population extended haplotype homozygosity index (Rsb) between pairs 
of populations in rows. e) Significance of pairwise IBD index (iR) between isolates from 
different sampling sites (rows). 
  
SNPs in drug resistance, erythrocyte invasion, gametocytogenesis, oocyst associated gene 
loci and antigenic loci were most differentiated between populations (figure 4a & 4b, table 
S5). These could be due to different histories but also selection from the different human 
and mosquito host across Africa. The drug loci (Pfaat1, Pfmdr1, Pfcrt, Pfdhfr, Pfdhps) and 
the IBD cluster on chromosome 12 showed signature of positive selection and haplotype 
differentiation across sampled populations (figure 4c-4e, table S5). Selection on the 
chromosome 12 cluster was strongest in Malawi and Ghana and these may have emerged 
independently. Further functional and clinical studies are urgent to determine if variants at 
these loci can compromise the efficacy of artemisinin combination treatments.  
 
Conclusion 
Plasmodium falciparum in Africa belong to major eastern, central and western subgroups, 
distant from a highly divergent Ethiopian population. These endogenous genomic lineages 
are the ancestral backbones on which adaptive loci such as drug resistance mutations may 
have emerged, recombined and shared haplotypes across Africa in both eastern and 
western directions. This pattern may be repeated against artemisinin derivatives, which 
select for loci on chromosome 12 under directional selection. As sustained drug pressure are 
reducing prevalence, lowering recombination and increasing clonality and isolation of 
populations, there is need for increased molecular and phenotypic vigilance. This should be 
extended to large swath of endemic populations in central Africa, where civil strife and 
other global health pathogen epidemics could maintain malaria and threaten efforts at 
elimination. 
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